|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
5,366,000 |
Market
Cap: |
7.51(M) |
Last
Volume: |
140,704 |
Avg
Vol: |
0 |
52
Week Range: |
$0.506 - $1.83 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile SELLAS Life Sciences Group is a late-stage clinical biopharmaceutical company focused on developing cancer immunotherapeutics for a range of cancer indications. Co.'s product candidates include galinpepimut-S (GPS) and nelipepimut-S (NPS). Co.'s primary product candidate, GPS, is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that targets the Wilms tumor 1 protein, which is present in 20 or more cancer types. NPS is a cancer immunotherapy targeting the human epidermal growth factor receptor 2 expressing cancers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
9,806 |
Total Sell Value |
$0 |
$0 |
$0 |
$25,516 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Schwartz Mark W. |
EVP, Chief Operating Officer |
|
2013-06-30 |
4 |
A |
$1.35 |
$10,614 |
D/D |
7,862 |
496,660 |
|
- |
|
Ahn Mark J |
President & CEO |
|
2013-06-30 |
4 |
A |
$1.35 |
$10,614 |
D/D |
7,862 |
108,108 |
|
- |
|
Dunlap Ryan |
Principal Accounting Officer |
|
2013-06-30 |
4 |
A |
$1.35 |
$1,848 |
D/D |
1,369 |
2,615 |
|
- |
|
Hillsberg Sanford |
Director |
|
2013-06-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
9,344 |
145,720 |
|
- |
|
Schwartz Mark W. |
EVP, Chief Operating Officer |
|
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
26,110 |
488,798 |
|
- |
|
Hillsberg Sanford |
Director |
|
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,327 |
145,703 |
|
- |
|
Ahn Mark J |
President & CEO |
|
2012-12-31 |
4 |
A |
$1.30 |
$9,968 |
D/D |
7,668 |
100,246 |
|
- |
|
Schwartz Mark W. |
EVP, Chief Operating Officer |
|
2012-12-31 |
4 |
A |
$1.30 |
$9,968 |
D/D |
7,668 |
462,688 |
|
- |
|
Dunlap Ryan |
Principal Accounting Officer |
|
2012-12-31 |
4 |
A |
$1.30 |
$1,620 |
D/D |
1,246 |
1,246 |
|
- |
|
Hillsberg Sanford |
Director |
|
2012-11-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
136,376 |
|
- |
|
Schwartz Mark W. |
EVP Chief Operating Officer |
|
2012-07-10 |
4 |
A |
$0.40 |
$8,750 |
D/D |
21,902 |
461,809 |
|
- |
|
Ahn Mark J |
President & CEO |
|
2012-07-10 |
4 |
A |
$0.40 |
$12,500 |
D/D |
31,289 |
92,578 |
|
- |
|
Schwartz Mark W. |
EVP Chief Operating Officer |
|
2012-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
89,322 |
439,907 |
|
- |
|
Hillsberg Sanford |
Director |
|
2012-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
31,966 |
156,376 |
|
- |
|
Schwartz Mark W. |
EVP Chief Operating Officer |
|
2011-12-31 |
4 |
A |
$0.40 |
$5,170 |
D/D |
12,924 |
350,585 |
|
- |
|
Ahn Mark J |
President & CEO |
|
2011-12-31 |
4 |
A |
$0.40 |
$12,516 |
D/D |
31,289 |
61,289 |
|
- |
|
Lee Kwang |
Principal Accounting Officer |
|
2011-12-07 |
4 |
B |
$0.60 |
$3,000 |
D/D |
5,000 |
5,000 |
2.66 |
- |
|
Ahn Mark J |
President & CEO |
|
2011-12-07 |
4 |
B |
$0.66 |
$6,590 |
D/D |
10,000 |
20,000 |
2.81 |
- |
|
Khvorova Anastasia |
Former CSO |
|
2011-09-24 |
4 |
A |
$0.00 |
$0 |
D/D |
76,923 |
137,482 |
|
- |
|
Ahn Mark J |
President and CEO |
|
2011-04-20 |
4 |
B |
$0.95 |
$9,500 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
Schwartz Mark W. |
EVP, Chief Operating Officer |
|
2011-04-13 |
4/A |
A |
$0.00 |
$0 |
D/D |
330,872 |
330,872 |
|
- |
|
Hillsberg Sanford |
Director |
|
2011-04-13 |
4/A |
A |
$0.00 |
$0 |
D/D |
120,838 |
126,838 |
|
- |
|
Schwartz Mark W. |
EVP Chief Operating Officer |
|
2011-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
337,661 |
337,661 |
|
- |
|
Kennedy Robert Eugene |
Vice President and CFO |
|
2011-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
5,006 |
379,294 |
|
- |
|
Kennedy Robert Eugene |
Vice President and CFO |
|
2011-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
374,288 |
374,288 |
|
- |
|
269 Records found
|
|
Page 6 of 11 |
|
|